Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Comment by bullman246on Feb 14, 2022 5:18pm
181 Views
Post# 34427944

RE:RE:RE:do the math

RE:RE:RE:do the mathAfter fleecing all of the LDS investors, now they're starting all over with a new scam and a new and naive bunch of investors/suckers.

They're using the same tactics all over again. Acquisitions that they can't afford with no revenue, promises of a patent, and tons of hype that will never amount to anything...  They'll just keep spending money, making more acquisitions, and relying on PP's and rollbacks to generate revenue (since they have none) while screwing investors with never ending stock dilution. Sound familiar?

Plenty of big hopes and dreams.. just like LDS had. Except COOL has no revenue at all to pay for any of it. Oh, and what ever happened to Cannastrips and it's promised patent approval?

By the time this scam ever makes it's first dime (if at all), investors/suckers will have taken such a loss of money, that they will never recoup. Just ask any LDS investor.

Oh, is anyone even aware that Brad Eckenweiler (the last CEO of LDS), was rewarded and appointed to COOL's BOD, after driving LDS and it's investors financially into the ground.  

Why would anyone invest in this scam, when it is years away from clinical trial approvals and any revenue? Furthermore, COOL's sister company C.TBI was delisted in July, as that fact was kept quiet. 

Just look at COOL's 10 year stock graph to see the almost 100% loss of stock price. Given these facts, who in their right mind would invest in this scam?
<< Previous
Bullboard Posts
Next >>